文献速递认知障碍与痴呆

阿尔茨海默病临床谱系中神经精神与认知症状的横断面及纵向关联

Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations.
PubMed 文献 · Neurology · 2021-08-19

本研究纳入阿姆斯特丹痴呆队列中1524例β-淀粉样蛋白阳性个体,涵盖主观认知下降、轻度认知障碍和 probable AD 痴呆,用神经精神量表(NPI)评估神经精神症状(NPS),发现NPS在各临床阶段均普遍存在,但个体内异质性大,且基线NPS与认知功能在痴呆期存在关联,纵向无关联。

要点

  • NPS在A+的SCD、MCI和痴呆阶段均普遍存在,临床相关NPS比例分别为54.0%、50.5%和66.0%。
  • 认知功能呈均匀逐渐下降,而NPS随时间呈现较大的个体内异质性。
  • 基线NPS与认知功能的横断面关联仅见于痴呆期,SCD和MCI期无关联,纵向均无关联。

核心结论

  • NPS和认知症状在AD临床谱系中均普遍存在,但二者随疾病进展的演变模式不同。

研究设计与样本

  • 单中心观察性研究,纳入阿姆斯特丹痴呆队列中A+的SCD(n=113)、MCI(n=321)和 probable AD 痴呆(n=1090),共1524例。
  • 使用NPI评估NPS,认知评估涵盖5个认知域和MMSE,纵向分析子样本n=520,平均随访1.8年(SD 0.7)。

主要发现

  • NPS患病率:至少1项NPS在SCD为81.4%、MCI为81.2%、痴呆为88.7%;至少1项临床相关NPS分别为54.0%、50.5%、66.0%。
  • 认知功能呈均匀逐渐下降,而NPS随时间呈现较大的个体内异质性。
  • 基线NPS与认知功能的横断面关联在痴呆期显著,NPI总分与MMSE的β范围为-0.18至-0.11(FDR校正p<0.05)。
  • SCD和MCI期无横断面关联(β范围-0.32至0.36,所有FDR校正p>0.05)。
  • 基线NPS与纵向认知功能在任何临床阶段均无关联(β范围-0.13至0.44,所有FDR校正p>0.05)。

临床怎么用

  • 在AD各临床阶段均应关注NPS的评估,尤其痴呆期NPS与认知功能存在横断面关联。
  • NPS的纵向演变个体差异大,需个体化动态监测,不能仅凭基线NPS预测认知下降轨迹。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: To investigate the prevalence and trajectories of neuropsychiatric symptoms (NPS) in relation to cognitive functioning in a cohort of β-amyloid-positive (A+) individuals across the Alzheimer disease (AD) clinical spectrum. METHODS: In this single-center observational study, we included all individuals who visited the Alzheimer Center Amsterdam and had a clinical diagnosis of subjective cognitive decline (SCD), mild cognitive impairment (MCI), or probable AD dementia and were A+. We measured NPS with the Neuropsychiatric Inventory (NPI), examining total scores and the presence of specific NPI domains. Cognition was assessed across 5 cognitive domains and with the Mini-Mental State Examination (MMSE). We examined trajectories including model-based trends for NPS and cognitive functioning over time. We used linear mixed models to relate baseline NPI scores to cognitive functioning at baseline (whole-sample) and longitudinal time points (subsample n = 520, mean 1.8 [SD 0.7] years follow-up). RESULTS: We included 1,524 A+ individuals from the Amsterdam Dementia Cohort with A+ SCD (n = 113), A+ MCI (n = 321), or A+ AD dementia (n = 1,090). NPS were prevalent across all clinical AD stages (≥1 NPS 81.4% in SCD, 81.2% in MCI, 88.7% in dementia; ≥1 clinically relevant NPS 54.0% in SCD, 50.5% in MCI, 66.0% in dementia). Cognitive functioning showed a uniform gradual decline; while in contrast, large intraindividual heterogeneity of NPS was observed over time across all AD groups. At baseline, we found associations between NPS and cognition in dementia that were most pronounced for NPI total scores and MMSE (range β = -0.18 to -0.11, false discovery rate [FDR]-adjusted p < 0.05), while there were no cross-sectional relationships in SCD and MCI (range β = -0.32 to 0.36, all FDR-adjusted p > 0.05). There were no associations between baseline NPS and cognitive functioning over time in any clinical stage (range β = -0.13 to 0.44, all FDR-adjusted p > 0.05). DISCUSSION: NPS and cognitive symptoms are both prevalent across the AD clinical spectrum, but show a different evolution during the course of the disease.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Eikelboom WS, van den Berg E, Singleton EH, et al. Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations. Neurology. 2021. PMID: 34413181. doi:10.1212/WNL.0000000000012598

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。